The Use of Knock-Out Mice Unravels Distinct Roles for mGlu2 and mGlu3 Metabotropic Glutamate Receptors in Mechanisms of Neurodegeneration/Neuroprotection
Authors:
- Corrado CortiCCCorrado Corti
- Giuseppe BattagliaGBGiuseppe Battaglia
- Gemma MolinaroGMGemma Molinaro
- Barbara RiozziBRBarbara Riozzi
- Anna PittalugaAPAnna Pittaluga
- Mauro CorsiMCMauro Corsi
- Manolo MugnainiMMManolo Mugnaini
- Ferdinando NicolettiFerdinando Nicoletti
- Valeria BrunoVBValeria Bruno
Open Access
- 1 August 2007
- journal article
- research article
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 27 (31) , 8297-8308
Abstract
Dual metabotropic glutamate 2/3 (mGlu2/3) receptor agonists have been examined with success in the clinic with positive proof of efficacy in several tests of anxiety and schizophrenia. Moreover, a large body of evidence has accumulated that these drugs have significant neuroprotective potential. An important discussion in the field deals with dissecting effects on mGlu2 versus effects on mGlu3 receptors, which is relevant for the potential use of subtype-selective agonists or allosteric activators. We addressed this issue using mGlu2 and mGlu3 receptor knock-out mice. We used mixed cultures of cortical cells in which astrocytes and neurons were plated at different times and could therefore originate from different mice. Cultures were challenged with NMDA for the induction of excitotoxic neuronal death. The mGlu2/3 receptor agonist, (−)-2-oxa-4-aminocyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY379268), was equally neuroprotective in cultures containing neurons from wild-type,mGlu2−/−, ormGlu3−/−mice. Neuroprotection was instead abolished when astrocytes lacked mGlu3 receptors, unless neuronal mGlu2 receptors were also absent. The latter condition partially restored the protective activity of LY379268. Cultures in which neurons originated frommGlu2−/−mice were also intrinsically resistant to NMDA toxicity. Inin vivoexperiments, systemic administration of LY379268 protected striatal neurons against NMDA toxicity in wild-type andmGlu2−/−mice but not inmGlu3−/−mice. In addition, LY379268 was protective against nigrostriatal degeneration induced by low doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine only in mice lacking mGlu2 receptors. We conclude that neuroprotection by mGlu2/3 receptor agonists requires the activation of astrocytic mGlu3 receptors, whereas, unexpectedly, activation of mGlu2 receptors might be harmful to neurons exposed to toxic insults.Keywords
This publication has 67 references indexed in Scilit:
- NAAG Reduces NMDA Receptor Current in CA1 Hippocampal Pyramidal Neurons of Acute Slices and Dissociated NeuronsNeuropsychopharmacology, 2004
- NAAG fails to antagonize synaptic and extrasynaptic NMDA receptors in cerebellar granule neuronsNeuropharmacology, 2004
- Metabotropic Glutamate Receptor Subtypes as Targets for Neuroprotective DrugsJournal of Cerebral Blood Flow & Metabolism, 2001
- Type 2 Metabotropic Glutamate (mGlu) Receptors Tonically Inhibit Transmitter Release in Rat Caudate Nucleus: In Vivo Studies with (2S,1′S,2′S,3′R)‐2‐(2′‐carboxy‐3′‐phenylcyclopropyl)glycine, a New Potent and Selective AntagonistEuropean Journal of Neuroscience, 1997
- TGF-β1 Protects Hippocampal Neurons Against Degeneration Caused by Transient Global IschemiaStroke, 1996
- Opposite effects of TGF-β1 on rapidly- and slowly-triggered excitotoxic injuryNeuropharmacology, 1996
- The inhibitory mGluR agonist, s-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal deathNeuropharmacology, 1995
- N‐Acetylaspartylglutamate Inhibits Forskolin‐Stimulated Cyclic AMP Levels via a Metabotropic Glutamate Receptor in Cultured Cerebellar Granule CellsJournal of Neurochemistry, 1993
- N‐Acetylaspartylglutamate acts as an agonist upon homomeric NMDA receptor (NMDAR1) expressed in Xenopus oocytesFEBS Letters, 1992
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976